5Y Capital

5Y Capital is a private equity and venture capital firm based in Shanghai, China, specializing in seed, startup, early venture, and growth capital investments. Established in 1992, the firm focuses on a diverse range of sectors, including healthcare, technology, fintech, internet services, consumer services, media, and life sciences, among others. It aims to support entrepreneurs in building innovative companies, particularly in China and other emerging markets in Asia/Pacific. Managing approximately USD 5 billion in dual-currency funds, 5Y Capital attracts investments from global sources, including sovereign wealth funds and family offices. The firm typically makes initial investments exceeding USD 500,000 per portfolio company. 5Y Capital operates under the Morningside Group, which is committed to socially responsible investing, particularly in educational opportunities and scientific research.

W. Anthony Brooke

Director

Zhe Chen

Managing Director

Yu Cheng

Partner

Ziyou Fu

Investor Relations Professional

Hanson Hu

Investment Manager

Lu Huang

Director

Levi Liu Kai

Partner

Yantao Lai

Investment Manager

Wentian Lian

VP

Tony Lian

Investment Manager

Sylvia Liu

Investment Manager

Qin Liu

Co-Founder, Investment Director & Board Member

Richard Liu

Founding Partner

Weimin Luo

Partner and Senior Consultant

Jianming Shi

Director of Business Development

Kejia Tang

Human Resource Director

Ji Tong

Investment Manager

Sixue Wang

Public Relations and Investor Relations Professional

Qiong Xue

CFO

Dan You

Executive Director

Ye Yuan

Partner

Oliver Zhang

Investment Manager

Fei Zhang

Partner

Bo Zhang

Managing Director

478 past transactions

evonetix

Series B in 2023
Evonetix Ltd is a biotechnology company based in Little Chesterford, United Kingdom, founded in 2015. The company focuses on developing innovative technology for the parallel synthesis of DNA on silicon arrays, which supports advancements in synthetic biology. Situated within the prestigious Cambridge cluster of high-tech and life science organizations, Evonetix aims to revolutionize DNA synthesis through novel techniques that enhance efficiency and capability. The team at Evonetix comprises experienced professionals from various scientific and engineering disciplines, bringing together a wealth of knowledge to drive the commercialization of their technology.

Epigenic Therapeutics

Seed Round in 2022
Epigenic Therapeutics is a biotech firm that offers gene editing therapy.

LANDBASE

Series B in 2022
LANDBASE is a food brand management company driven by the concept of innovation & fashion. Committed to integrating global R&D and production resources, LANDBASE utilizes frontier food processing technologies to redefine traditional foods and build fashionable foods for the future.

Airspace Link

Series B in 2022
Airspace Link digitizes local airspace for urban air mobility. It provides government, citizen, and business drone solutions to support local government airspace management, fostering citizen empowerment, and business innovation through consumer and b2b air logistical support and services. It was founded in 2018 and is based in Detroit, Michigan.

XYZ Robotics

Series B in 2022
XYZ Robotics develops AI-enabled robotic perception and manipulation technology for logistics and manufacturing automation. The company develops autonomous robotic solutions for put wall sorting and goods-to-person picking. Its robot sorts unorganized, random warehouse goods into groups of customer orders. The solution embodies its strength in deep learning and robotics.

HAI ROBOTICS

Series D in 2022
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in developing autonomous case-handling robotic systems for warehouse automation. The company offers a range of intelligent automation solutions, including a goods-to-person system, smart in-plant logistics, and multi-tier steel platform solutions, suitable for diverse operational scenarios. HAI ROBOTICS is a pioneer in the field, having launched its first autonomous case-handling robot, HAIPICK, in 2015. The HAIPICK system has demonstrated significant advantages, enhancing warehouse operational efficiency by three to four times and increasing storage density by 80% to 130%. The company is committed to research and development, holding numerous patents and continuously improving its products to meet the needs of a growing customer base, which includes major clients like DHL Supply Chain, BEST Supply Chain, and Philips. With the capability to deploy automation solutions within a week, HAI ROBOTICS aims to optimize warehousing operations through advanced robotics and artificial intelligence.

VisionNav Robotics

Series C in 2022
VisionNav Robotics Limited designs, develops, and manufactures industrial vehicle vision driverless navigation equipment for indoor and outdoor scenes. Its products include vision navigation tray unmanned forklift, visual navigation balance heavy unmanned forklift, vision navigation forward-moving unmanned forklift, visual navigation unmanned tractor, and industrial vehicle driverless system solution. The company serves to e-commerce logistics, aviation logistics, third party logistics, retail fast moving goods, and home appliance sectors. The company was founded in 2015 and is based in Shenzhen, China.

METiS Therapeutics

Series B in 2022
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.

Eko Health

Series C in 2022
Eko harnesses the power of smartphones and cloud data for monitoring patients with cardiovascular diseases. It has built a platform of non-invasive cardiovascular monitoring devices, clinical software, and point-of-care decision support algorithms to improve the delivery of cardiovascular care. In 2015, Eko launched the Eko Core Digital Stethoscope, the first FDA-cleared digital stethoscope on the market to wirelessly stream heart and lung sound to HIPAA-compliant software. For the first time in history, patient sounds can be integrated with electronic health records (EHRs) for more seamless referrals, documentation, and monitoring. Eko was established in 2013 and is based in Berkeley, California.

Regenerative Bio

Angel Round in 2022
Regenerative Bio is a pioneering biotechnology company focused on anti-aging solutions through the integration of artificial intelligence and advanced computing technologies. The company is dedicated to researching and developing ingredients, formulations, and therapies aimed at mitigating the effects of aging and enhancing overall health. By leveraging AI, quantum physics, and high-throughput preparation methods, Regenerative Bio seeks to improve cellular health and energy metabolism, ultimately promoting longer, healthier lives. Their innovative approach combines pharmaceutical technology with biological research, addressing age-related health issues and contributing to the field of longevity science.

Curve Health

Series A in 2022
Curve Health, Inc. operates as an online platform that delivers senior care facilities by combining telemedicine, smart billing, health information exchange, and predictive analytics. The platform enables the physicians to remotely care for patients. The company offers skilled nursing facilities to take care of patients in the facility; and emergency medical services. Curve Health, Inc. was incorporated in 2020 and is based in New York, New York.
GreenLight Biosciences is a biotechnology company that specializes in RNA-based solutions for agricultural and pharmaceutical applications. Founded in 2008 and headquartered in Medford, Massachusetts, with an additional location in North Carolina, the company utilizes its Unconstrained Metabolism technology platform to convert renewable substrates into valuable chemicals and fuels. This platform allows for significant flexibility and control in the production process. GreenLight is also focused on developing RNA products aimed at improving crop management, plant protection, and animal health, while advancing vaccine development and pandemic preparedness. In addition to these applications, the company is working on mRNA-based vaccine candidates targeting seasonal and pandemic influenza, as well as other emerging viruses, to enhance public health. Through its innovations, GreenLight aims to provide sustainable solutions that contribute to global food security and health.

Big Health

Series C in 2022
Big Health is a London-based company that develops and markets digital healthcare solutions focused on improving mental health and sleep disorders. Its flagship product, Sleepio, is a digital sleep improvement program that utilizes Cognitive Behavioral Therapy techniques to address individual sleep challenges. The platform offers fully-automated, personalized therapeutic sessions, allowing users to engage with their specific issues and track their progress. In addition to Sleepio, Big Health provides a broader digital healthcare portal that delivers customized behavioral programs aimed at various mental health concerns, all designed in consultation with medical professionals to ensure efficacy and relevance.

ReviR Therapeutics

Seed Round in 2022
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Virtue Diagnostics

Series B in 2022
VIRTUE Diagnostics(Suzhou)Co.,Ltd. develops in vitro diagnostic platform. The company offers technology platforms including clinical mass spectrometry, multiplex immunohistochemistry for pathology-based cancer detection, and a molecular and immunoassay platform. VIRTUE Diagnostics(Suzhou)Co.,Ltd. was founded in 2019 and is based in Suzhou, China with a research and development office in Singapore.

Almond Fintech

Seed Round in 2021
Almond Fintech is a developer of a cross-border payment platform that facilitates remittances and payments across various providers and borders. The company's platform offers currency exchange services and ensures interoperability between mobile wallets and financial services. This enables individuals and businesses to send and receive money using their existing wallets, streamlining the process of cross-border transactions. By focusing on enhancing mobile financial services, Almond Fintech aims to simplify and improve the user experience for both personal and business financial activities.

Treelab

Series A in 2021
Treelab is a Shanghai-based company founded in 2019 that specializes in developing a productivity tool designed for non-technical users to create customized business systems. The platform enables individuals and organizations to develop personalized software applications without the need for programming skills. Treelab's tool is utilized to build solutions across various domains, including project management, sales customer relationship management (CRM), form collection, and human resource management. By empowering users to create their own software, Treelab aims to streamline business processes and enhance productivity.

Xbiome

Series B in 2021
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

Vastai Technologies

Series B in 2021
Vastai Technologies is focused on developing AI chips for the optimization of computer vision and video processing.

Graphics Origin

Angel Round in 2021
Graphics Origin is a graphics technology company focused on providing advanced productivity tools for 3D content creation.

METiS Therapeutics

Series A in 2021
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.

Laizanbao Technology

Series A in 2021
Lai Zanbao is a cross-border e-commerce business solution service provider, and its target positioning is a one-stop e-commerce integrated service provider in the Southeast Asian market. Based on past experience and data accumulation in the field of e-commerce and its own international warehousing and distribution system, Lai Zanbao provides merchants in Southeast Asia with a full chain of services from supply chain selection, logistics performance, e-commerce operations to localized marketing.

Abogen Biosciences

Series C in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Moore Threads

Series A in 2021
Moore Threads providing GPU (Graphics Processing Unit) technology and services to corporate clients in a wide variety of sectors such as gaming, the creative industry, and artificial intelligence.

ieso

Series B in 2021
Ieso Digital Health Ltd. specializes in providing online evidence-based cognitive behavioral therapy (CBT) to individuals facing various mental health challenges, including anxiety and depression. The company's unique online service facilitates real-time communication between accredited therapists and patients through a secure virtual environment, where sessions are conducted via text. This approach not only mirrors traditional face-to-face interactions but also offers greater convenience for users. Ieso began its operations in the UK in 2000 and has since expanded into the US market, collaborating with Medicaid and commercial health plans to enhance access to mental health services. The company’s therapy model has demonstrated effectiveness, requiring fewer sessions to achieve recovery and showing improved outcomes compared to conventional therapy methods. Ieso serves a diverse clientele, including health providers, private individuals, and businesses, and is recognized for its rapid growth in the digital health sector.

Generate Biomedicines

Series B in 2021
Generate Biomedicines, Inc. develops a platform to invent novel antibodies, peptides, enzymes, receptors, and other therapeutic proteins. It offers Generative Biology, a machine learning based solution that learns from all known proteins in order to encode and apply the fundamental principles of how genetic sequences lead to protein structure and function for creating novel protein sequences with optimized therapeutic potential. Its Generative Biology is applied to all protein modalities and generate novel proteins with desired functions and solutions that interact potently and specifically with therapeutic targets. Generate Biomedicines, Inc. was formerly known as Generate Biologics, Inc. and changed its name to Generate Biomedicines, Inc. in March 2020. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Zhongke Guosheng

Angel Round in 2021
Zhongke Guosheng is a bio-based materials R&D firm that designs and develops furan-based bio-based materials.

Block Renovation

Series C in 2021
Block Renovation is a renovation platform that combines architect-grade design, construction labor, and materials into a streamlined renovation experience. Block’s mission is to give homeowners a better way to improve the spaces they live in, and to give contractors a better way to work. Founded by Koda Wang and Luke Sherwin, Block simplifies a complex and convoluted process and delivers an intuitive experience for completing a beautiful home renovation.

DeepCure

Series A in 2021
DeepCure Inc. offers drugs discovery services using artificial intelligence technology. Its products include De-novo Lead Discovery, Artificial Intelligence-driven Lead Optimization, and MoIDB. De-novo Lead Discovery uses artificial intelligence algorithms to analyze drug candidates from virtual library. Artificial Intelligence-driven Lead Optimization identifies optimization steps to improve the development of drugs. MolDB is designed to maximize scale, diversity, and synthesizability of chemical search space. DeepCure Inc. develops new drug through molecular feature extraction, MoIDB, artificial intelligence predictive modeling and feedback loop. The company was founded in 2018 and is based in Boston, Massachusetts.

Robigo

Pre Seed Round in 2021
Robigo is a biopesticide engineering the plant microbiome to reduce disease in crops.

Moody

Series C in 2021
Moody is a developer of disposable colored contact lenses brand. The company's products are well branded and packaged, as well as hygienic for users, enabling consumers to purchase quality color contact lens products.

Axbio

Series B in 2021
Axbio Inc. develops and manufactures technology for genetic sequencing. It offers products, such as stool genome extraction kit, blood genome extraction kit, saliva genome extraction kit, and bacterial genome extraction kit. The company provides sequencing and diagnostic systems, disposable biochips, and reagents. Axbio Inc. was founded in 2016 and is based in Shenzhen, China.

Signet Therapeutics

Seed Round in 2021
Signet Therapeutics is a biopharmaceutical startup focusing on developing innovative targeted cancer drugs using novel disease models.

EasyExpunctions

Venture Round in 2021
EasyExpunctions.com provides the most cost-effective and comprehensive Expunction solution for individuals interested in erasing all traces of their criminal record without an attorney. Their patent-pending process is not only unique amongst other legal software providers, they are the only online legal software dedicated to generating legal documents focused on individual reputation management.

PhiGent Robotics

Seed Round in 2021
PhiGent Robotics offers autonomous driving solutions.

HT Aero

Series A in 2021
HT Aero aspires to be the pioneer of urban air mobility (UAM) and is dedicated to producing safe and intelligent electric flying vehicles. which combine automotive and aerospace technologies to realize domestic air-travel usage at scale.

Kappa Pay

Pre Seed Round in 2021
Kappa Pay is a fintech platform that leverages blockchain solutions to facilitate instant merchant pay and cross-border payments. Whether sending money locally or abroad, Kappa makes payments as seamless as sending a WhatsApp message.

BetterUp

Series E in 2021
BetterUp Inc. is a leadership development platform based in San Francisco, California, founded in 2013. The company provides a mobile-based solution for organizations, including Fortune 500 companies, aimed at enhancing employee performance through a science-backed methodology. BetterUp's platform facilitates on-demand virtual coaching sessions, allowing users to identify and practice new behaviors and mindsets essential for achieving high performance in a rapidly changing environment. The platform tracks and measures individual growth, helping employees cultivate skills that support both personal and professional development. Its diverse clientele includes notable companies like Genentech, Logitech, and Workday, reflecting its commitment to fostering an adaptive workforce.

Homee

Series B in 2021
Homee, Inc. provides a mobile application that connects enterprises, customers, and service providers in a home service transaction. Its technology platform allows users to find and hire handyman, plumbers, electricians, HVAC service providers, and others. The company serves homeowners, renters, and property managers. Homee, Inc. was founded in 2017 and is based in Tampa, Florida.

Semios

Private Equity Round in 2021
SemiosBio Technologies Inc. offers innovative pest management solutions for growers of tree fruits, nuts, and grapes globally. The company has developed the Semios platform, which enables real-time monitoring and control of agricultural operations through a comprehensive network of sensors. This platform provides continuous coverage and includes features such as automated pheromones, pest traps, and pest pressure notifications, along with frost monitoring and alerts. Additionally, it evaluates disease risk, monitors irrigation, and assesses soil conditions, helping growers make informed decisions to optimize crop quality while reducing agricultural inputs. Founded in 2009 and headquartered in Vancouver, Canada, Semios also operates locations in Fresno, California; Wenatchee, Washington; and Heerlen, the Netherlands.

HAI ROBOTICS

Series C in 2021
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in developing autonomous case-handling robotic systems for warehouse automation. The company offers a range of intelligent automation solutions, including a goods-to-person system, smart in-plant logistics, and multi-tier steel platform solutions, suitable for diverse operational scenarios. HAI ROBOTICS is a pioneer in the field, having launched its first autonomous case-handling robot, HAIPICK, in 2015. The HAIPICK system has demonstrated significant advantages, enhancing warehouse operational efficiency by three to four times and increasing storage density by 80% to 130%. The company is committed to research and development, holding numerous patents and continuously improving its products to meet the needs of a growing customer base, which includes major clients like DHL Supply Chain, BEST Supply Chain, and Philips. With the capability to deploy automation solutions within a week, HAI ROBOTICS aims to optimize warehousing operations through advanced robotics and artificial intelligence.

HAI ROBOTICS

Series D in 2021
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in developing autonomous case-handling robotic systems for warehouse automation. The company offers a range of intelligent automation solutions, including a goods-to-person system, smart in-plant logistics, and multi-tier steel platform solutions, suitable for diverse operational scenarios. HAI ROBOTICS is a pioneer in the field, having launched its first autonomous case-handling robot, HAIPICK, in 2015. The HAIPICK system has demonstrated significant advantages, enhancing warehouse operational efficiency by three to four times and increasing storage density by 80% to 130%. The company is committed to research and development, holding numerous patents and continuously improving its products to meet the needs of a growing customer base, which includes major clients like DHL Supply Chain, BEST Supply Chain, and Philips. With the capability to deploy automation solutions within a week, HAI ROBOTICS aims to optimize warehousing operations through advanced robotics and artificial intelligence.

Etern

Series B in 2021
Etern is developing small molecule innovative drugs for oncology therapies.

XtalPi

Series D in 2021
XtalPi Inc. is a pharmaceutical technology company founded in 2014 and headquartered in Cambridge, Massachusetts, with additional offices in China. The company specializes in leveraging artificial intelligence and advanced computing to accelerate drug development. Its offerings include XtalForc, a visual force field calculation software; XtalVision, a tool for crystal structure prediction; and Renova, which supports AI-driven research and development. XtalPi provides a range of services such as crystal structure prediction and determination, solid state testing and analysis, crystallization process development, and small molecule drug design. By collaborating with pharmaceutical companies, XtalPi uses its predictive algorithms to facilitate the development of new drugs and the creation of patents, enhancing the efficiency of the drug discovery process.

Bota Biosciences

Series B in 2021
Bota Biosciences designs and develops synthetic bioengineering technology platform for bio-manufacturing. The company develops cloud databases and intelligent control software suitable for biotechnology development and production. Bota Biosciences was founded in 2019 and is based in Hangzhou, China.

Amylyx Pharmaceuticals

Series C in 2021
Amylyx Pharmaceuticals, Inc. develops novel therapeutic for Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. It offers AMX0035, an investigational therapy and a fixed-dose co-formulation of two active compounds, such as sodium phenylbutyrate and Taurursodiol optimized to treat both the energy crisis in the mitochondria and the toxic, unfolded proteins in the endoplasmic reticulum, disrupting the neurological chain of events that leads to patient suffering. The company’s pipeline includes amyotrophic lateral sclerosis, Wolfram syndrome, and Alzheimer’s diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is based in Cambridge, Massachusetts.

XYZ Robotics

Series B in 2021
XYZ Robotics develops AI-enabled robotic perception and manipulation technology for logistics and manufacturing automation. The company develops autonomous robotic solutions for put wall sorting and goods-to-person picking. Its robot sorts unorganized, random warehouse goods into groups of customer orders. The solution embodies its strength in deep learning and robotics.

Desty

Seed Round in 2021
Desty is a digital platform that serves as a single online destination for creators, influencers, and merchants to promote and sell their products.

Block Renovation

Series B in 2021
Block Renovation is a renovation platform that combines architect-grade design, construction labor, and materials into a streamlined renovation experience. Block’s mission is to give homeowners a better way to improve the spaces they live in, and to give contractors a better way to work. Founded by Koda Wang and Luke Sherwin, Block simplifies a complex and convoluted process and delivers an intuitive experience for completing a beautiful home renovation.

Fount Bio

Series A in 2021
Fount Bio is a life science company that applies proprietary advances in glycopolymer research for skin health. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts, United States.

Bombax

Series A in 2021
Xiaoice is an AI company that develops a chatbot that acts as a digital assistant with the capability to understand human conversations. Xiaoice allows cross-platform interactions, enabling users to enjoy the convenience of artificial intelligence. Xiaoice is designed as a teenage girl and is touted as an empathic computing framework focusing on longer back-and-forth conversations with humans instead of simply answering questions or obeying commands like most bots. Its technology covers natural language processing, computer voice, computer vision, and AI content generation.

neoX BIOTECH

Venture Round in 2021
neoX BIOTECH is a biotechnology company that develops antigen-based cancer vaccine through a deep understanding of biophysics and the use of artificial intelligence. It develops a neoantigen prediction and TCR screening platform. The company was founded in 2018 and is based in Beijing, China.

AgileX

Venture Round in 2021
AgileX Robotics (Dongguan) CO., Ltd designs and manufactures mobile robot products. It offers Unmanned ground vehicle (UGV), automated guided vehicle (AGV), and steering-by-wire modified electric vehicles. It serves logistics transportation, security patrolling, and agricultural and animal husbandry industries. The company was founded in 2017 and is based in Dongguan, China with an additional office in Shenzhen, China.

Triastek

Series B in 2021
Triastek Co. Ltd. manufactures 3D printed pharmaceuticals and related medical equipment. It offers blockbuster drugs, orphan drugs, and complex drug delivery technologies. It also offers drug 3D printing, such as three-dimensional drug structure formulation design, 3D printing pharmaceutical equipment, and drug product development methods for patent families in China, US, Europe, and Japan. The company also owns Melt Extrusion Deposition (MED), a 3D printing technology universally applicable to solid formulations. The company was founded in 2015 and is based in Nanjing, China.

Alentis Therapeutics

Series B in 2021
Alentis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland, focused on developing novel treatments for advanced liver diseases. Founded in 2019, the company aims to address conditions such as liver fibrosis, cirrhosis, and liver cancer, particularly targeting Claudin-1 positive tumors and organ fibrosis. Alentis employs a research platform that utilizes clinically relevant readouts and single-cell RNA sequencing of patient liver tissues, enabling the development of effective therapies to combat fibrosis and reverse the progression of these diseases. Through its innovative approach, Alentis Therapeutics seeks to improve outcomes for patients suffering from severe liver-related health issues.
Stealth BioTherapeutics is a clinical-stage biotechnology company dedicated to developing therapies for diseases associated with mitochondrial dysfunction, which includes both rare genetic disorders and common age-related conditions. The company's lead product candidate, Elamipretide, aims to address these health issues, while additional candidates like SBT-20 and SBT-272 are being explored for their potential benefits in stabilizing mitochondrial function and treating neurodegenerative diseases, respectively. Founded in 2006 and based in George Town, Cayman Islands, Stealth BioTherapeutics collaborates with patients and advocacy groups to deepen its understanding of the challenges faced by those with mitochondrial diseases and to raise awareness of their therapeutic programs.

Coin Metrics

Series B in 2021
Coin Metrics Inc. is an online publisher specializing in blockchain and cryptocurrency data, offering a range of market and network analytics to various industries. Founded in 2017 and based in Cambridge, Massachusetts, the company provides several key products, including the CM Network Data Pro, which delivers historical crypto network data in a detailed format for institutional clients. Additionally, Coin Metrics offers the CM Market Data Feed, a standardized solution for trade, candle, and order book data from multiple exchanges, and CM Reference Rates, which provides fixed pricing for various assets quoted in U.S. dollars. By focusing on transparent and actionable data, Coin Metrics enables stakeholders to better understand and utilize public crypto networks.

Catalant

Venture Round in 2021
Catalant Technologies, Inc. is a Boston-based software company that specializes in providing solutions for strategy execution to global enterprises. Founded in 2013 and formerly known as HourlyNerd, the company offers a platform that assists organizations in transforming their strategic objectives into actionable plans. Catalant's software enables businesses to align work, access both internal and external resources, collaborate effectively, and measure the value of their efforts, facilitating faster execution of mission-critical projects. The platform connects enterprises with a global network of over 65,000 experts and more than 27,000 boutique firms, providing a streamlined approach to sourcing expertise on demand. By leveraging best-in-class tools for talent management, Catalant helps clients improve efficiency and effectiveness in achieving their strategic goals.

SoupMaster

Series B in 2021
SoupMaster is a Chinese restaurant chain and retail brand. It provides various nutritious soups for pregnant women, patients with a demand for health recuperation, and other people pursuing high-quality life.

HAI ROBOTICS

Series B in 2021
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in developing autonomous case-handling robotic systems for warehouse automation. The company offers a range of intelligent automation solutions, including a goods-to-person system, smart in-plant logistics, and multi-tier steel platform solutions, suitable for diverse operational scenarios. HAI ROBOTICS is a pioneer in the field, having launched its first autonomous case-handling robot, HAIPICK, in 2015. The HAIPICK system has demonstrated significant advantages, enhancing warehouse operational efficiency by three to four times and increasing storage density by 80% to 130%. The company is committed to research and development, holding numerous patents and continuously improving its products to meet the needs of a growing customer base, which includes major clients like DHL Supply Chain, BEST Supply Chain, and Philips. With the capability to deploy automation solutions within a week, HAI ROBOTICS aims to optimize warehousing operations through advanced robotics and artificial intelligence.

Stavvy

Series A in 2021
Stavvy is a modern lending experience designed to connect lenders with their title, settlement, and appraisal vendors. The Stavvy Connect is a fully-integrated, digital mortgage vendor platform that allows mortgage banking professionals to seamlessly and securely communicate and access vendor data & deliverables without fragmentation or exposure to unnecessary risk. The Stavvy Notarize empowers title agents, lawyers, notaries and other real estate professionals to leverage the power of web conference technology to conduct virtual closings and meetings in real-time.

Arctic Vision

Series B in 2021
Arctic Vision (Shanghai) Biotechnology Co., Ltd. is a clinical-stage specialty ophthalmology company based in China, focused on developing innovative therapies to meet the unmet clinical needs in ophthalmic diseases. The company has a portfolio of breakthrough technologies aimed at addressing various eye care challenges, including rare diseases through gene therapy. Established by prominent life sciences investors, Arctic Vision is led by a team of experienced professionals from the ophthalmic industry, bringing extensive expertise in research, development, and commercialization of eye care products. The company aims to deliver effective solutions not only in China but also across Asia and globally.

Zhishan Weixin Biotechnology

Series A in 2021
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.

Pony.ai

Series C in 2021
Pony.ai, Inc. is a company that specializes in developing artificial intelligence software for autonomous mobility applications. Founded in 2016 by James Peng and Tiancheng Lou, Pony.ai is headquartered in Fremont, California, with additional offices in San Francisco and in China. The company creates full-stack autonomous driving solutions that enhance the manufacturing of automated vehicles. Its technology utilizes advanced algorithms and AI to accurately interpret the vehicle's environment, enabling it to predict the actions of surrounding drivers and navigate safely. In addition to its software solutions, Pony.ai operates a public-facing Robotaxi service, further demonstrating its commitment to advancing autonomous transportation.

neoX BIOTECH

Series A in 2021
neoX BIOTECH is a biotechnology company that develops antigen-based cancer vaccine through a deep understanding of biophysics and the use of artificial intelligence. It develops a neoantigen prediction and TCR screening platform. The company was founded in 2018 and is based in Beijing, China.

Rockley Photonics

Venture Round in 2021
Rockley Photonics manufactures photonics chips and custom integrated packaged products. It offers products for broad market applications ranging from communications to consumers. The company is focused on sales of chipsets plus the customer-specific design of photonics chips and custom integrated packaged products. In this way, Rockley Photonics leverages its investment in photonics platform research and process development across broader market applications. Rockley Photonics was founded in 2013 and is headquartered in Pasadena, CA.

Liran cosmetics

Series B in 2021
Liran cosmetics operates as a men’s personal care brand. Liran cosmetics provides products catered to men covering skincare, body wash, hair care, body fragrance, and makeup, among others.

Innodem Neurosciences

Series A in 2021
Innodem Neurosciences develops an artificial intelligence (AI) driven mobile software technology which allows paralyzed and intubated patients to communicate with caregivers solely through eye movements. It develops Pigio, a mobile application that uses eye-tracking technology to interact with the user. The company was founded in 2016 and is based in Outremont, Canada.

Keep

Series F in 2021
Keep is a young team that loves sports and is also a group of Geeks who pursue the ultimate experience. They focus on application development in the field of mobile sports, advocate the spirit of open sharing, do not imitate, do not follow suit, and only do cool products. In the age of their lives, the fitness culture is awakening, there should be more professional tools, a more pure community, and make the body easier. This is what Keep is doing. They hope that through technology-driven, more people will love fitness and enjoy sports.

Galixir

Series A in 2020
Galixir is an artificial intelligence technology to promote the research and development of new drugs. Our artificial intelligence drug discovery platform can help drug research and development scientists greatly save time and cost in drug development. At the same time, our platform also provides comprehensive patent protection coverage for the drugs developed. Relying on cutting-edge artificial intelligence technology, Xingyao combines engineering chemistry, computational chemistry, computational biology, and cloud computing technologies to serve the various processes of drug development.

AliveX

Angel Round in 2020
AliveX is a developer of an AI-driven immunology platform that focuses on biomarker discovery for early cancer screening, precision medicine, and treatment monitoring. By integrating multi-omics data, artificial intelligence, and computational biology, the platform aims to decode the human immune system. This innovative approach enables collaboration with leading clinicians, research institutions, and pharmaceutical companies to address significant clinical challenges. AliveX's efforts are directed towards transforming life sciences research and advancing the next generation of precision diagnostics and treatments in the field of immunology.

Shukun Technology

Series C in 2020
Shukun (Beijing) Network Technology Co., Ltd. operates as an artificial intelligence based medical technology company. It offers CareSphere Advisor that includes CoronaryDoc, a coronary heart disease intelligent auxiliary diagnosis system; FFRDoc, an intelligent blood flow reserve fraction CT-FFR measurement system; CACScoreDoc for calculating calcification points; and AortaDoc, an aortic intelligent diagnosis system. The company was founded in 2017 and is based in Beijing, China with a branch in Shanghai.

Horizon Robotics

Series C in 2020
Beijing Horizon Robotics Technology Co., Ltd. develops chips for robots. The company was founded in 2015 and is based in China.

Medbanks

Series E in 2020
Medbanks Network Technology Co. Ltd. provides data processing services to healthcare industry. The company develops multi center database that manages and mines data that reflects China's patient population. Medbanks Network Technology Co. Ltd. was founded in 2014 and is based in Beijing, China.

XKool Technology

Venture Round in 2020
XKool Technology is focuses on applying artificial intelligence solution to urban planning and architectural design. It is committed to assisting urban planning, architectural design and development decisions intelligent, and empowering AI to promote the development of the entire architectural industry. As the leading company to apply artificial intelligence to urban planning and architectural design, XKool has successfully implemented “artificial intelligence design cloud platform” and “artificial intelligence design cloud service” using cutting-edge technologies such as deep learning, machine learning, and big data. Through simple operation and intelligent services in the cloud, XKool would assist design institutes, real estate developers, planning departments to design and decision-making faster and more accurately.

DEEPEXI

Series A in 2020
Beijing Dip Technology Co., Ltd. (hereinafter referred to as “Drip Technology”) is a leader and builder of digital transformation of enterprises, providing enterprise-level business consulting, solutions, products and technology research and development based on leading Internet architecture. The company was incorporated in May 2018 with a registered capital of 20 million. At present, the company has 160 employees and its headquarters is located in Beijing. It has branches in major cities including Guangzhou, Shenzhen, Nanjing and Chengdu. The R&D team is over 80%, mainly in Guangzhou, Nanjing and Chengdu. People, masters dozens of people, have the top domestic AI team and open source team to join.

DEEPEXI

Series A in 2020
Beijing Dip Technology Co., Ltd. (hereinafter referred to as “Drip Technology”) is a leader and builder of digital transformation of enterprises, providing enterprise-level business consulting, solutions, products and technology research and development based on leading Internet architecture. The company was incorporated in May 2018 with a registered capital of 20 million. At present, the company has 160 employees and its headquarters is located in Beijing. It has branches in major cities including Guangzhou, Shenzhen, Nanjing and Chengdu. The R&D team is over 80%, mainly in Guangzhou, Nanjing and Chengdu. People, masters dozens of people, have the top domestic AI team and open source team to join.

Vastai Technologies

Series A in 2020
Vastai Technologies is focused on developing AI chips for the optimization of computer vision and video processing.

Xbiome

Series B in 2020
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

GalaxySpace

Series C in 2020
GalaxySpace develops and builds LEO broadband satellite constellation, and 5G communication network. The company’s satellite applications include monitoring of airport, parking, and oil reserves, as well as assess land types and uses. GalaxySpace was founded in 2016 and is based in Haidian, China.

Gongsibao

Series B in 2020
Gongsibao provides an O2O enterprise service platform. Gongsibao was founded in 2014 and is based in Chaoyang, China.

Zilliz

Series B in 2020
Zilliz is a technology company founded in 2017 and headquartered in San Francisco, California, with additional offices in China. It specializes in developing an intelligent data processing platform that enhances query performance, utilizing GPU hardware acceleration. Zilliz is renowned for its open-source project Milvus, which focuses on AI-powered unstructured data analysis and vector similarity search. Since its release in 2019, Milvus has gained significant traction, attracting over 400 enterprise users and engaging more than 120 contributors on GitHub. Its applications are diverse, encompassing areas such as image processing, computer vision, natural language processing, speech recognition, recommendation engines, and drug development. In 2020, Milvus became an incubation-stage project at the LF AI & Data Foundation, reflecting its active development and community support.